Vanguard International High Dividend Yield ETF (VYMI) is rated Buy, driven by sector catalysts in financials, energy, and healthcare supporting dividend growth and capital appreciation. VYMI outperforms peers with a 5-year average annual return of 14.13%, a 3.61% dividend yield, and attractive valuation metrics (P/E 13.6x, P/B 1.8x). Key holdings like HSBC, Royal Bank of Canada, Roche, Novartis, and Shell provide resilience, growth, and sustainable dividends, reinforcing VYMI's competitive positioning.
The Buy survived an adverse setup: US growth rebounded hard, yet VYMI still delivered positive absolute returns with the value rotation staying structurally intact throughout. The delivered Fed hike confirms higher-for-longer, compressing long-duration US growth multiples while rewarding VYMI's short-duration value tilt, especially its heavy financials weighting. Currency, not a broken thesis, drove most of the S&P lag; that drag is now fading as euro weakness plateaus and the yen stays capped.
Vanguard International High Dividend Yield ETF is a buy at $105.60, despite a 19.7% YTD gain, due to robust financials exposure. VYMI's 43.6% allocation to financials aligns with rising global rates and improving bank earnings, supporting the current investment thesis. Compared to SCHY, VYMI delivers superior total returns without sacrificing yield, and its sector concentration is offset by broad company diversification.
The Vanguard International High Dividend Yield ETF (NASDAQ:VYMI) has quietly become one of the more popular income parking spots for retirees this year, and the math behind that shift is straightforward.
Vanguard International High Dividend Yield Index Fund offers global diversification and has outperformed the S&P 500, delivering a 55% total return since last coverage. VYMI provides a 3.4% starting dividend yield with an 8.86% five-year dividend CAGR, making it attractive for income-focused investors seeking international exposure. The ETF is heavily weighted toward financials (42.85%) and rebalances annually, introducing sector concentration risk but mitigating single-stock impact through broad diversification.
The Vanguard International High Dividend Yield ETF (NASDAQ:VYMI) sits in a lot of income portfolios as the foreign-stock complement to a domestic dividend sleeve, and its payouts have grown noticeably over the past three years.
This article provides in-depth coverage of Vanguard's $19B International High Dividend Yield ETF, a well-established and well-diversified fund with a cheap 0.07% ER and an estimated yield approaching 4%. VYMI offers adequate exposure to European, Pacific, Canadian, and Emerging Markets, though is heavily tilted to Financials (42%). Nevertheless, strong dividend growth is likely sustainable, given how my fundamental analysis reveals high sales and EPS growth rates, 15% profit margins, and a 14% portfolio-level ROIC.
VYMI: Strong International Equity ETF, Cheap Valuation, Good Dividend Yield And Growth
Vanguard International High Dividend Yield ETF earns a buy rating for its sustainable dividends, growth momentum, and attractive valuation versus peers and the U.S. market. VYMI offers superior diversification, a low 0.07% expense ratio, and a 3.47% yield, with dividend growth potential supported by robust fundamentals in top holdings like HSBC, Novartis, and Shell. Key holdings exhibit strong dividend sustainability and growth, with low payout ratios and healthy margins, positioning VYMI for continued capital appreciation and dividend increases.
Confluence Wealth Services Inc. lifted its holdings in shares of Vanguard International High Dividend Yield ETF (NASDAQ: VYMI) by 5.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,336,183 shares of the company's stock after acquiring an
The Vanguard International High Dividend Yield ETF offers triple the dividend yield of the S&P 500 index. The VYMI earned total returns of more than 45% in the past year.
Two of Vanguard's international equity ETFs have been strong performers. But the high dividend ETF has bested its larger peer for the past 10 years.